AIM
To compare the cardiorenal efficacy and safety of finerenone, sodium-glucose cotransporter 2 inhibitors (SGLT2i), semaglutide and finerenone-SGLT2i combination therapy in diabetic kidney disease (DKD).
MATERIALS AND METHODS
PubMed, Embase and CENTRAL were searched through July 9, 2026 for randomized trials involv...
Zi-Jian Zhou, Ling-Hua Fu, Dan Chen et al.· Diabetes, obesity and metabo...· 0 citations
IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide, and inflammatory bowel disease (IBD) comprises a group of chronic, relapsing inflammatory bowel disorders. Although IgAN and IBD differ in clinical manifestations, both involve interactions among genetic susceptibility, epigenetic abnormalities, an...
Lusia S. Yi, Ran Zhang, Yang Yang et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.